NCT00322049 A Phase I/II Trial of Tetravalent Live Attenuated Dengue Vaccine in Flavivirus Antibody Naive Infants Status COMPLETED Phase PHASE1/PHASE2
NCT00321763 Study to Demonstrate the Lot-to-lot Consistency and to Evaluate the Safety of an Adjuvanted Influenza Vaccine Candidate Status COMPLETED Phase PHASE2
NCT00321477 A Study Of GW679769 Compared To Placebo In Women With Overactive Bladder Status COMPLETED Phase PHASE2
NCT00321438 Observational Study of HIV-Infected Subjects With X4-Tropic or Non-Phenotypeable Virus Status TERMINATED Phase N/A
NCT00320463 Compare Immunogenicity & Safety of 2 Formulations of GSK Biologicals' DTPa-HBV-IPV/Hib Vaccine Given in Healthy Infants Status COMPLETED Phase PHASE3
NCT00320411 GW572016 In Patients With ErbB2 Over - Expressing Advanced Or Metastatic Breast Cancer Status COMPLETED Phase PHASE2
NCT00320398 Total Hip Replacement Study Of GSK576428 (Fondaparinux Sodium) Status COMPLETED Phase PHASE3
NCT00320385 Lapatinib In Combination With Trastuzumab Versus Lapatinib Monotherapy In Subjects With HER2-positive Metastatic Breast Cancer Status COMPLETED Phase PHASE3
NCT00320359 Topotecan Plus Cisplatin Versus Etoposide Plus Cisplatin In 1st Line Extensive Disease Small Cell Lung Cancer Status COMPLETED Phase PHASE3
NCT00320307 Comparison of Abacavir Following Once-Daily And Twice-Daily Administration In HIV Infected Subjects Status COMPLETED Phase PHASE1
NCT00319332 A Comparative Study Of Iodine I 131 Tositumomab Therapeutic Regimen Versus Ibritumomab Tiuxetan Therapeutic Regimen Status WITHDRAWN Phase PHASE3
NCT00319137 An Adaptive Design Trial Of GW274150 In The Treatment Of Acute Migraine Status COMPLETED Phase PHASE2
NCT00319098 Study to Evaluate the Safety and Immunogenicity of a Pandemic Influenza Vaccine in Adults Aged 18 Years and Above Status COMPLETED Phase PHASE3
NCT00318656 24-Hour Glycemia: Rosiglitazone Versus Glimepiride In Type 2 Diabetes Status COMPLETED Phase PHASE4